Database : MEDLINE
Search on : Lithiasis [Words]
References found : 5900 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 590 go to page                         

  1 / 5900 MEDLINE  
              next record last record
select
to print
Photocopy
Full text

[PMID]: 25375751
[Au] Autor:Schiappacasse G; Aguirre J; Soffia P; Silva CS; Zilleruelo N
[Ad] Address:1 Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
[Ti] Title:CT findings of the main pathological conditions associated with horseshoe kidneys.
[So] Source:Br J Radiol;88(1045):20140456, 2015 Jan.
[Is] ISSN:1748-880X
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:Horseshoe kidney (HSK) is the most common renal fusion anomaly, with a prevalence of 0.25% among the general population. It consists of kidney fusion across the midline. HSK can be present as an isolated condition in 30%, but there is a wide variety of associated abnormalities. The most frequent include ureteropelvic obstruction, lithiasis and infections. There is also a higher risk of kidney lesions in trauma and an increased incidence of malignancies. Awareness of embryology and anatomy is essential to assess and understand the complications affecting HSK. CT is an excellent method for identification of its main findings.
[Mh] MeSH terms primary: Kidney Diseases
Kidney/abnormalities
Tomography, X-Ray Computed/methods
[Mh] MeSH terms secundary: Humans
Kidney/radiography
Kidney Diseases/congenital
Kidney Diseases/pathology
Kidney Diseases/radiography
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Em] Entry month:1504
[Cu] Class update date: 150717
[Lr] Last revision date:150717
[Js] Journal subset:AIM; IM
[Da] Date of entry for processing:141219
[St] Status:MEDLINE
[do] DOI:10.1259/bjr.20140456

  2 / 5900 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 26094400
[Au] Autor:Rumjancev AA; Dutov VV; Saakjan AA; Popov DM; Beljaev VV; Beljaev DV
[Ti] Title:[PERCUTANEOUS CYSTOLITHOTRIPSY: THE FIRST CLINICAL EXPERIENCE].
[So] Source:Urologiia;(1):112-4, 2015 Jan-Feb.
[Is] ISSN:1728-2985
[Cp] Country of publication:Russia (Federation)
[La] Language:rus
[Ab] Abstract:This paper reviews results of examination and treatment for benign prostatic hyperplasia (BPH) and infravesical obstruction in 16 patients observed in Department of Urology of Zhukovsky CCH in 2013-2014. Most operated patients required particularly careful approach to the surgery planning due to advanced age and multiple comorbidities. Treatment of all patients was carried out in a single therapeutic session performed in two stages. Percutaneous cystolithotripsy was performed on the first stage and subsequently transurethral resection of the prostate (TURP) was carried out. It was found, that combination of minimally invasive percutaneous approach and TURP is the most sparing way to restore lower urinary tract urodynamics and eliminate bladder stones in all operated patients. With appropriate patient selection and a clear definition of indications, proposed treatment combination is a promising and effective strategy in management of patient with urolithiasis with infravesical obstruction and BPH.
[Mh] MeSH terms primary: Lithotripsy/methods
Prostatic Hyperplasia/surgery
Transurethral Resection of Prostate/methods
Ureteral Obstruction/surgery
Urolithiasis/therapy
[Mh] MeSH terms secundary: Aged
Humans
Lithotripsy/adverse effects
Male
Middle Aged
Transurethral Resection of Prostate/adverse effects
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Em] Entry month:1507
[Js] Journal subset:IM
[Da] Date of entry for processing:150622
[St] Status:MEDLINE

  3 / 5900 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 26094378
[Au] Autor:Andrjuhin MI; Motin PI; Pul'bere SA; Israfilov MN
[Ti] Title:[REHABILITATION OF PATIENTS WITH URIC ACID AND MIXED UROLITHIASIS].
[So] Source:Urologiia;(1):4-7, 2015 Jan-Feb.
[Is] ISSN:1728-2985
[Cp] Country of publication:Russia (Federation)
[La] Language:rus
[Ab] Abstract:This paper presents evaluation of rehabilitation effectiveness of 113 patients aged 19-78 years diagnosed as having mixed and uric acid stones. 88 patients with uric acid stones 0,5-2,5 cm were assigned to group 1 and treated with Trometamol N parenteral litholis and a complex metaprophilaxis by dietary supplements Prolit and Urisan. 25 patients with mixed stones 1-3,5 cm were allocated to group 2 and treated with external shock wave lithotripsy and complex metaprophilaxis by dietary supplements Prolit Super Septo and Urisan. Positive results were achieved in all the patients. In the patients of group 1 the stones were completely dissolved. In group 2 treatment resulted in stone disintegration and clearance of small fragments 0,4 cm after partial dissolution.
[Mh] MeSH terms primary: Anti-Infective Agents, Urinary/administration & dosage
Dietary Supplements
Pipemidic Acid/administration & dosage
Uric Acid
Urolithiasis/rehabilitation
[Mh] MeSH terms secundary: Adult
Aged
Female
Humans
Male
Middle Aged
Urolithiasis/diagnosis
Urolithiasis/metabolism
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Nm] Name of substance:0 (Anti-Infective Agents, Urinary); 268B43MJ25 (Uric Acid); LT12J5HVR8 (Pipemidic Acid)
[Em] Entry month:1507
[Js] Journal subset:IM
[Da] Date of entry for processing:150622
[St] Status:MEDLINE

  4 / 5900 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25501968
[Au] Autor:Papapoulos SE
[Ad] Address:Leiden University Medical Center, Leiden, The Netherlands.
[Ti] Title:Olav Bijvoet 1928-2014.
[So] Source:J Bone Miner Res;29(12):2527-8, 2014 Dec.
[Is] ISSN:1523-4681
[Cp] Country of publication:United States
[La] Language:eng
[Mh] MeSH terms primary: Hypercalcemia
Neoplasms
Osteitis Deformans
Osteoporosis
Urolithiasis
[Mh] MeSH terms secundary: Animals
History, 20th Century
History, 21st Century
Humans
Hypercalcemia/history
Hypercalcemia/metabolism
Neoplasms/history
Neoplasms/metabolism
Osteitis Deformans/history
Osteitis Deformans/metabolism
Osteoporosis/history
Osteoporosis/metabolism
Portraits as Topic
Urolithiasis/history
Urolithiasis/metabolism
[Pt] Publication type:BIOGRAPHY; HISTORICAL ARTICLE; JOURNAL ARTICLE
[Ps] Personal name as subject:Bijvoet O
[Em] Entry month:1507
[Js] Journal subset:IM
[Da] Date of entry for processing:141216
[St] Status:MEDLINE
[do] DOI:10.1002/jbmr.2367

  5 / 5900 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 25409506
[Au] Autor:Lafaurie M; De Sousa B; Ponscarme D; Lapidus N; Daudon M; Weiss L; Rioux C; Fourn E; Katlama C; Molina JM
[Ad] Address:Department of Infectious Diseases, Saint-Louis Hospital, Paris, France, and University of Paris Diderot Paris 7, Sorbonne Paris Cité, INSERM U941, Paris, France....
[Ti] Title:Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study.
[So] Source:PLoS One;9(11):e112836, 2014.
[Is] ISSN:1932-6203
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:OBJECTIVES: Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis have not been fully investigated. METHODS: We reviewed all cases of ATV-containing urolithiasis identified by infrared spectrophotometry among HIV-infected patients over a 5-year period to describe their clinical features and outcome. A case-control study was performed to identify risk factors associated with ATV-associated urolithiasis using univariate and multivariate logistic regression analyses. RESULTS: 30 cases of ATV-associated urolithiasis were analyzed. Patients were mostly men (87%), median age: 45.5 years, median CD4 cell count: 443 cells/µL and 97% had plasma HIV RNA level <50 cp/mL. Median time between the initiation of ATV-containing regimen and the diagnosis of urolithiasis was 3.1 years. Patients presented with flank pain in 90% and macroscopic hematuria in 82.6%, 34% had renal dysfunction and 44.8% needed ureteroscopic treatment. In univariate analysis, chronic hepatitis C, a history of urolithiasis, prior use of indinavir, ATV duration, undetectable plasma HIV RNA, use of ritonavir as a booster and serum free bilirubin level were associated with ATV-urolithiasis. Multivariate models retained serum free bilirubin level (OR: 2.31, p<0.02) and either ATV duration (OR:  = 1.42, p = <0.03) or a history of urolithiasis (OR = 4.79, p<0.02) when adjusting on serum free bilirubin level as risk factors associated with urolithiasis. CONCLUSIONS: ATV-containing urolithiasis are associated with frank clinical symptoms and may require surgical intervention. A high serum bilirubin level, a long exposure to ATV and a history of urolithiasis are risk factors for this rare adverse event.
[Mh] MeSH terms primary: Anti-HIV Agents/adverse effects
Oligopeptides/adverse effects
Pyridines/adverse effects
Urolithiasis/chemically induced
[Mh] MeSH terms secundary: Adult
Anti-HIV Agents/therapeutic use
Case-Control Studies
Female
HIV Infections/drug therapy
Humans
Male
Middle Aged
Oligopeptides/therapeutic use
Pyridines/therapeutic use
Risk Factors
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Anti-HIV Agents); 0 (Oligopeptides); 0 (Pyridines); QZU4H47A3S (atazanavir)
[Em] Entry month:1507
[Js] Journal subset:IM
[Da] Date of entry for processing:141121
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0112836

  6 / 5900 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25409068
[Au] Autor:Massinha P; Nunes N; Liberal R; Ávila F; Santos V; Rego A; Pereira JR; Paz N; Duarte MA
[Ad] Address:Hospital do Divino Espírito Santo de Ponta Delgada, Department of Gastroenterology, Ponta Delgada, Portugal....
[Ti] Title:Usefulness of direct peroral cholangioscopy in the management of intrahepatic lithiasis.
[So] Source:Endoscopy;46 Suppl 1 UCTN:E553, 2014.
[Is] ISSN:1438-8812
[Cp] Country of publication:Germany
[La] Language:eng
[Mh] MeSH terms primary: Bile Ducts, Intrahepatic
Cholelithiasis/therapy
Endoscopy, Digestive System
[Mh] MeSH terms secundary: Cholangiopancreatography, Magnetic Resonance
Cholangitis/etiology
Cholelithiasis/complications
Cholelithiasis/diagnosis
Humans
Male
Middle Aged
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1507
[Js] Journal subset:IM
[Da] Date of entry for processing:141121
[St] Status:MEDLINE
[do] DOI:10.1055/s-0034-1377952

  7 / 5900 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25409057
[Au] Autor:Olano C; Mönkemüller K
[Ad] Address:Basil I. Hirschowitz Endoscopic Center of Excellence, Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Alabama, USA.
[Ti] Title:Novel ERCP technique using a pushing catheter as a "mini-overtube" to remove a migrated metal stent from the bile duct.
[So] Source:Endoscopy;46 Suppl 1 UCTN:E534-5, 2014.
[Is] ISSN:1438-8812
[Cp] Country of publication:Germany
[La] Language:eng
[Mh] MeSH terms primary: Cholangiopancreatography, Endoscopic Retrograde/methods
Device Removal/methods
Lithiasis/therapy
Liver Diseases/therapy
Prosthesis Failure
[Mh] MeSH terms secundary: Bile Ducts
Caroli Disease/complications
Caroli Disease/therapy
Cholangiopancreatography, Endoscopic Retrograde/instrumentation
Cholangitis, Sclerosing/complications
Cholangitis, Sclerosing/therapy
Device Removal/instrumentation
Female
Humans
Lithiasis/complications
Liver Diseases/complications
Middle Aged
Stents/adverse effects
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE
[Em] Entry month:1507
[Js] Journal subset:IM
[Da] Date of entry for processing:141121
[St] Status:MEDLINE
[do] DOI:10.1055/s-0034-1377637

  8 / 5900 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25443947
[Au] Autor:Sahota A; Parihar JS; Capaccione KM; Yang M; Noll K; Gordon D; Reimer D; Yang I; Buckley BT; Polunas M; Reuhl KR; Lewis MR; Ward MD; Goldfarb DS; Tischfield JA
[Ad] Address:Department of Genetics, Rutgers University, Piscataway, NJ. Electronic address: sahota@biology.rutgers.edu....
[Ti] Title:Novel cystine ester mimics for the treatment of cystinuria-induced urolithiasis in a knockout mouse model.
[So] Source:Urology;84(5):1249.e9-15, 2014 Nov.
[Is] ISSN:1527-9995
[Cp] Country of publication:United States
[La] Language:eng
[Ab] Abstract:OBJECTIVE: To assess the effectiveness of l-cystine dimethyl ester (CDME), an inhibitor of cystine crystal growth, for the treatment of cystine urolithiasis in an Slc3a1 knockout mouse model of cystinuria. MATERIALS AND METHODS: CDME (200 µg per mouse) or water was delivered by gavage daily for 4 weeks. Higher doses by gavage or in the water supply were administered to assess organ toxicity. Urinary amino acids and cystine stones were analyzed to assess drug efficacy using several analytical methods. RESULTS: Treatment with CDME led to a significant decrease in stone size compared with that of the water group (P = .0002), but the number of stones was greater (P = .005). The change in stone size distribution between the 2 groups was evident by micro computed tomography. Overall, cystine excretion in urine was the same between the 2 groups (P = .23), indicating that CDME did not interfere with cystine metabolism. Scanning electron microscopy analysis of cystine stones from the CDME group demonstrated a change in crystal habit, with numerous small crystals. l-cysteine methyl ester was detected by ultra-performance liquid chromatography-mass spectrometer in stones from the CDME group only, indicating that a CDME metabolite was incorporated into the crystal structure. No pathologic changes were observed at the doses tested. CONCLUSION: These data demonstrate that CDME promotes formation of small stones but does not prevent stone formation, consistent with the hypothesis that CDME inhibits cystine crystal growth. Combined with the lack of observed adverse effects, our findings support the use of CDME as a viable treatment for cystine urolithiasis.
[Mh] MeSH terms primary: Cystine/analogs & derivatives
Cystinuria/drug therapy
Urolithiasis/drug therapy
[Mh] MeSH terms secundary: Amino Acid Transport Systems, Basic/genetics
Amino Acid Transport Systems, Neutral/genetics
Animals
Chromatography, Liquid
Cystine/chemistry
Cystinuria/urine
Male
Mass Spectrometry
Mice
Mice, Knockout
Microscopy, Electron, Scanning
X-Ray Microtomography
[Pt] Publication type:JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Name of substance:0 (Amino Acid Transport Systems, Basic); 0 (Amino Acid Transport Systems, Neutral); 0 (L-cystine dimethylester); 0 (Slc3a1 protein, mouse); 48TCX9A1VT (Cystine)
[Em] Entry month:1502
[Cu] Class update date: 150711
[Lr] Last revision date:150711
[Js] Journal subset:IM
[Da] Date of entry for processing:141202
[St] Status:MEDLINE

  9 / 5900 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text

[PMID]: 25408751
[Au] Autor:Iorgulescu A; Turcu F; Iordache N
[Ad] Address:General Surgery Clinic, "Sf. Ioan" Hospital, Bucharest.
[Ti] Title:ERCP after bariatric surgery--literature review and case report.
[So] Source:J Med Life;7(3):339-42, 2014 Sep 15.
[Is] ISSN:1844-3117
[Cp] Country of publication:Romania
[La] Language:eng
[Ab] Abstract:Obesity is a disease which has become more prevalent in Romania. Bariatric surgical procedures are among the treatment options for obese patients. Obesity and the metabolic disorders induced by it are risk factors for gallstones formation and their complications. ERCP is a minimally invasive therapeutic procedure indicated in the treatment of choledochal lithiasis and its complications. ERCP is generally considered the most difficult endoscopic procedure from the technical point of view. The authors have proposed to consider the possibility of performing therapeutic ERCP in patients who have undergone bariatric procedures. Literature data are reviewed and the case of a patient treated in a minimally invasive (laparoendoscopic) way for cholecyst and choledocholithiasis after longitudinal gastrectomy is presented.
[Mh] MeSH terms primary: Bariatric Surgery/methods
Bile Ducts/pathology
Cholangiopancreatography, Endoscopic Retrograde/methods
Lithiasis/etiology
Lithiasis/pathology
Obesity/surgery
[Mh] MeSH terms secundary: Cholangiopancreatography, Endoscopic Retrograde/standards
Female
Humans
Middle Aged
Obesity/complications
Romania
Ursodeoxycholic Acid/administration & dosage
[Pt] Publication type:CASE REPORTS; JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T; REVIEW
[Nm] Name of substance:724L30Y2QR (Ursodeoxycholic Acid)
[Em] Entry month:1507
[Cu] Class update date: 150106
[Lr] Last revision date:150106
[Js] Journal subset:IM
[Da] Date of entry for processing:141121
[St] Status:MEDLINE

  10 / 5900 MEDLINE  
              first record previous record
select
to print
Photocopy
SciELO Brazil full text

[PMID]: 26154558
[Au] Autor:Korkes F
[Ad] Address:Faculdade de Medicina do ABC, Santo André, SP, Brazil.
[Ti] Title:Urinary lithiasis: the perfect balance.
[So] Source:Einstein (Sao Paulo);13(2):IX-XI, 2015 Apr-Jun.
[Is] ISSN:2317-6385
[Cp] Country of publication:Brazil
[La] Language:eng; por
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1507
[Js] Journal subset:IM
[St] Status:In-Data-Review


page 1 of 590 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information